Cluster randomised controlled trial of the impact of the Australian Cancer Trials online website
- Conditions
- CancerCancer - Other cancer types
- Registration Number
- ACTRN12608000273381
- Lead Sponsor
- Dr Rachel Dear
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Patients invited to participate in the study must be: 1) Patients starting treatment for the first time. For example: new patients, patients not initially suitable for chemotherapy but are currently suitable due to symptomatic disease or improved performance status. 2) Patients in whom a treatment change is anticipated. For example: in the adjuvant setting a patient with early breast cancer finishing adjuvant chemotherapy and about to start adjuvant endocrine therapy and in the metastatic setting patients with progressive disease needing to change chemotherapy or all lines of chemotherapy utilised. 3) Patients with email and internet access. 4) Patients due to see their medical oncologist in 2 weeks time over a period of 4 to 8 weeks (longer may be necessary).
Medical oncologists working outside NSW and Victoria and medical oncologists who do not have email and internet access. Patients who do not have email and internet access, who are already participating in a clinical trial and do not have command of English.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.